Debate

DOI: 10.4244/EIJ-E-24-00062

Drug-coated balloon angioplasty for in-stent restenosis: pros and cons

Fernando Alfonso1, MD, PhD; Robert A. Byrne2, PhD, MB, BCh; Bruno Scheller3, MD, PhD; Eric van Belle4, MD, PhD; Julinda Mehilli5,6, MD, PhD

In-stent restenosis (ISR) is the leading cause of failure of percutaneous coronary intervention (PCI). Primarily based on neoatherosclerosis or neointimal hyperplasia, ISR has become less common with advancements in stent technology. Both drug-eluting stents (DES) and drug-coated balloons (DCB) have been shown to represent valid alternative options for the treatment of ISR, although they come with distinct benefits and limitations. More specifically, despite a substantial equipoise in the treatment of ISR of bare metal stents (BMS), DCB have been demonstrated to be less effective than repeat DES implantation in treating DES-ISR. As such, 2024 European guidelines on chronic coronary syndromes recommend DES over DCB for the treatment of DES-ISR, with a Class I recommendation. However, numerous anatomical and procedural factors (e.g., lesion complexity, small vessels, stent underexpansion, or prior multiple stent layers) may impact outcomes and could inform treatment modality selection. In light of the current evidence, whether PCI with DES implantation should be adopted as the standard treatment for ISR or whether the decision between DCB and DES should be based on a tailored approach remains controversial.

Pros

...
Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 2
Jan 20, 2025
Volume 21 Number 2
View full issue


Key metrics

Suggested by Cory
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved